Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease (Ment-COPD)
Chronic Obstructive Pulmonary Disease (COPD)
About this trial
This is an interventional basic science trial for Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
Inclusion Criteria: The subject has given written consent to participate in the study Diagnosis of COPD confirmed by spirometry and a FEV1 < 80% of predicted post bronchodilator at baseline age 18 years or older able to cycle able to understand and talk Swedish to participate in the study procedures, as judged by the Investigator. Exclusion Criteria: Resting peripheral oxygen saturation (SpO2) < 92% hospitalization or clinical instability during the last four weeks treatment with supplementary oxygen at rest or during exercise contraindication to exercise testing in accordance with clinical practice guidelines expected survival shorter than six months as judged by the Investigator medical conditions including congestive heart failure, acute coronary artery disease, neuromuscular diseases, severe psychiatric illness, and olfaction disorder.
Sites / Locations
- Lund University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Menthol
Placebo
In the trial, 30 minutes prior to performing submaximal CPET, participants will be administered, L-menthol patch which will be attached to the inside of a facemask that is connected to the breathing circuit.
For placebo, the patch will contain a similarly patch with strawberry scent.